CAS RN: 107910-75-8
Ganciclovir sodium
Product Availability
Choose a grade to view its available package options.
10 package records9 with current stock3 grade groups
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20250512 |
100g |
In stock |
| Inquiry |
| Batchno.20250826 |
100mg |
In stock |
| Inquiry |
| Batchno.20250325 |
1g |
In stock |
| Inquiry |
| Batchno.20260627 |
25g |
Out of stock |
| Inquiry |
| Batchno.20260503 |
500mg |
In stock |
| Inquiry |
| Batchno.20250912 |
5g |
In stock |
| Inquiry |
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20250207 |
1ml |
In stock |
| Inquiry |
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20250225 |
1g |
In stock |
Shanghai | Inquiry |
| Batchno.20260129 |
250mg |
In stock |
Shanghai | Inquiry |
| Batchno.20251001 |
5g |
In stock |
Shanghai | Inquiry |
-
Product code:
starshine_CAS107910-75-8
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
107910-75-8 / sodium 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)purin-6-olate
AKOS025401444 | AC-1671
Standard CAS: 107910-75-8
Multi CAS: Yes
Basic Information
CAS
107910-75-8
Multi CAS
Yes
Molecular Formula
C9H12N5NaO4
Molecular Weight
277.210000
Exact Mass
277.078698
SMILES
C1=NC2=C(N1COC(CO)CO)N=C(N=C2[O-])N.[Na+]
InChI
InChI=1S/C9H13N5O4.Na/c10-9-12-7-6(8(17)13-9)11-3-14(7)4-18-5(1-15)2-16;/h3,5,15-16H,1-2,4H2,(H3,10,12,13,17);/q;+1/p-1
InChIKey
JJICLMJFIKGAAU-UHFFFAOYSA-M
Synonyms
AKOS025401444
AC-1671
Computed Properties
Structural Parameters
Heavy atom count
19
Aromatic heavy atom count
9
Fraction Csp3
0.44
Rotatable bonds
5
H-bond acceptors
9
H-bond donors
3
Molar refractivity
58.23
TPSA
142.37
LogP / Solubility
WLOGP
-5.19
MLOGP
-4.55
XLogP3
-5.19
Consensus LogP
-4.98
Log S (ESOL)
1.69
Class (ESOL)
Highly soluble
Log S (Ali)
1.91
Class (Ali)
Highly soluble
Log S (SILICOS-IT)
2.24
Class (SILICOS-IT)
Highly soluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-8.09
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.55
Leadlikeness
Yes
Synthetic Accessibility
1.5
Safety & Transport
Pictogram(s)
Health Hazard
Signal
Danger
GHS Hazard Statements
H350 (100%): May cause cancer [Danger Carcinogenicity]
H360 (100%): May damage fertility or the unborn child [Danger Reproductive toxicity]
Precautionary Statement Codes
P203, P280, P318, P405, and P501